News
Construction on the site will begin in the fall and is expected to be finished by 2027. North Chicago is already home to ...
AbbVie will invest $195 million in its North Chicago, Illinois, manufacturing plant to expand domestic API production in the ...
The expansion is part of AbbVie’s larger $10 billion commitment to U.S. investment in the face of Trump’s tariff threats.
AbbVie will invest $195M to expand API manufacturing at its North Chicago plant, boosting U.S. pharmaceutical innovation, ...
As pharma companies big and small play up their U.S. investment plans during the second Trump administration, the particulars ...
20h
TipRanks on MSNAbbVie’s ABBV-453 Study: A New Hope for Multiple Myeloma Treatment
Abbvie (($CC:ABBV.CUR)) announced an update on their ongoing clinical study. AbbVie is conducting a Phase 1/2 study titled A ...
20h
TipRanks on MSNAbbVie’s Phase 3 Study on OnabotulinumtoxinA: A Potential Game-Changer for Forehead Lines
Abbvie (($CC:ABBV.CUR)) announced an update on their ongoing clinical study. AbbVie is conducting a Phase 3 clinical study ...
AbbVie Inc.'s Q2 2025 results showcase Skyrizi & Rinvoq's growth, strong finances, and a promising pipeline. Click for my ...
As for its neuroscience portfolio, AbbVie has added $300 million, putting its projection for the year at $10.5 billion, which ...
Over the past five years, ABBV has experienced a negative one-day return following its earnings announcements in 65% of ...
AbbVie, a global leader in life sciences, announced Tuesday the company’s is investing $195 million to expand its North ...
Steve Grzanich has the business news of the day with the Wintrust Business Minute. Abbott Laboratories spinoff AbbVie will ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results